Skip to Main Content

Esperion Therapeutics, Inc.

ESPR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
ESPR Income Statement
ESPR Balance Sheet
ESPR Cash Flow

Recent trades of ESPR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ESPR Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ESPR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ESPR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by ESPR's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods of making bempedoic acid and compositions of the same May. 21, 2024
  • Patent Title: Methods of making bempedoic acid and compositions of the same Mar. 12, 2024
  • Patent Title: Methods of making bempedoic acid and compositions of the same Sep. 19, 2023
  • Patent Title: Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease Sep. 05, 2023
  • Patent Title: Methods of making bempedoic acid and compositions of the same Mar. 28, 2023
  • Patent Title: Methods of making bempedoic acid and compositions of the same Aug. 09, 2022
  • Patent Title: Hydroxyl compounds and compositions for cholesterol management and related uses Mar. 09, 2021
  • Patent Title: Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease Feb. 09, 2021
  • Patent Title: Hydroxyl compounds and compositions for cholesterol management and related uses Nov. 06, 2018
  • Patent Title: Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses Aug. 14, 2018
  • Patent Title: Hydroxyl compounds and compositions for cholesterol management and related uses Apr. 18, 2017
  • Patent Title: Apolipoprotein mixtures Apr. 04, 2017
  • Patent Title: Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses Sep. 27, 2016
  • Patent Title: Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses Apr. 14, 2015
  • Patent Title: Hydroxyl compounds and compositions for cholesterol management and related uses Apr. 07, 2015
  • Patent Title: Ketone compounds and compositions for cholesterol management and related uses Mar. 10, 2015
  • Patent Title: Ketone compounds and compositions for cholesterol management and related uses Feb. 04, 2014
  • Patent Title: Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses Jan. 07, 2014
  • Patent Title: Hydroxyl compounds and compositions for cholesterol management and related uses Jul. 30, 2013
  • Patent Title: Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses Nov. 13, 2012
  • Patent Title: Cycloalkyl-hydroxyl compounds and compositions for cholesterol management Apr. 10, 2012
  • Patent Title: Ketone compounds and compositions for cholesterol management and related uses Dec. 27, 2011
  • Patent Title: Cycloalkyl-hydroxyl compounds and compositions for cholesterol management Nov. 29, 2011
  • Patent Title: Dihydroxyl compounds and compositions for cholesterol management and related uses Nov. 23, 2010
  • Patent Title: Hydroxyl compounds and compositions for cholesterol management and related uses Oct. 12, 2010
  • Patent Title: Compositions comprising ether compounds and pharmaceutical uses therefor May. 04, 2010
  • Patent Title: Ketone compounds and compositions for cholesterol management and related uses Apr. 27, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of ESPR in WallStreetBets Daily Discussion

ESPR News

Recent insights relating to ESPR

CNBC Recommendations

Recent picks made for ESPR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ESPR

ESPR Top Shareholders
Shareholder
Shares Held
ESPR Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ESPR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ESPR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top